QGEN
QIAGEN N.V.
NYSE · usd
QIAGEN N.V. (QGEN) trades at $50.39 (+0.34%) as of 7:30:05 PM EDT on Oct 23, 2026, +13.08% over the past month. Market cap is $10.37B, with 3.6 days to cover in short interest.
Stock performance
How QIAGEN N.V. (QGEN) stock has performed from one day to one year, with its 52-week range.
- 1D
- +0.34%
- 1W
- +9.23%
- 1M
- +13.08%
- YTD
- +12.05%
- 1Y
- +4.11%
- 52-wk range
- $32.53 – $57.82
Key statistics
Today's trading snapshot for QGEN: day range, open, previous close, volume and market cap.
- Day range
- $50.33 – $50.45
- Open
- $50.38
- Prev close
- $50.22
- Volume
- 7.14M
- Market cap
- $10.37B
- Shares out
- 206.07M
Dividend history and stock splits
QIAGEN N.V.'s recent dividend payments and stock splits.
Dividends
- $0.35ex-div Jul 7, 2026
- $2.29ex-div Jan 8, 2026
- $0.25ex-div Jul 2, 2025
- $1.26ex-div Jan 29, 2025
Splits
- 35-for-36Jan 29, 2025
- 24.25-for-25Jan 30, 2024
- 26-for-27Jan 25, 2017
QGEN short interest
How heavily QGEN is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 3.6
- Short interest
- 7.68M
- Avg volume
- 2.16M
As of · reported to FINRA twice monthly.
QGEN news
The latest news and headlines about QIAGEN N.V. (QGEN).
- Halper Sadeh LLC is Investigating Whether QGEN, VCTR, RLYB are Obtaining Fair Deals for their ShareholdersnegativeGlobeNewswire Inc.· Oct 22, 2026
- Saudi Arabia Non-Invasive Prenatal Testing Market 2026-2034: Executive Report | NGS Adoption and Healthcare Investment Drive 13.35% CAGR Toward US$162.16 MillionpositiveGlobeNewswire Inc.· Oct 15, 2026
- Global Microbiology Testing Market to Grow Rapidly at a CAGR of ~9% by 2034 | DelveInsightpositiveGlobeNewswire Inc.· Oct 14, 2026
- Global Microfluidics Market by Product Type, Application, End User, and Region, 2026-2036 | $48.04 Billion Opportunity Driven by Point-of-Care Diagnostics and AutomationpositiveGlobeNewswire Inc.· Oct 6, 2026
- Europe Point of Care Diagnostics Market Size and Forecast, 2021 - 2031 | Market to Reach US$21.4 Billion by 2031 as Rapid Testing and Molecular Innovation Drive 13.4% CAGRpositiveGlobeNewswire Inc.· Oct 5, 2026
Frequently asked questions
What is the QIAGEN N.V. (QGEN) stock price today?
QIAGEN N.V. (QGEN) is trading at $50.39 (+0.34% on the day) as of 7:30:05 PM EDT on Oct 23, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is QIAGEN N.V.?
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics.
What is the short interest in QGEN?
As of Sep 30, 2026, QGEN has 7.68M shares short and 3.6 days to cover.
Does QIAGEN N.V. (QGEN) pay a dividend?
Yes. QIAGEN N.V. (QGEN)'s most recent dividend was $0.35 per share, with an ex-dividend date of Jul 7, 2026. Full QGEN dividend history is available from the Massive API.
What exchange is QGEN listed on?
QIAGEN N.V. (QGEN) trades on NYSE in USD.
Build with AI
Build an analysis of QGEN with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a QGEN analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.